Pictet Asset Management (Switzerland)’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,733	Closed	-$284K	–	2030
2023 Q1	$284K	Hold	3,733	–	–	﹤0.01%	1528
2022 Q4	$310K	Hold	3,733	–	–	﹤0.01%	1485
2022 Q3	$296K	Buy	+3,733	New	+$315K	﹤0.01%	1243

Other funds holding XBI

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

APF

Alaska Permanent Fund Juneau, Alaska $1.44B AUM 23.16% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s XBI Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2023, closing a stake of 3,733 shares — an estimated $284K sold.

Pictet Asset Management (Switzerland) first reported a position in XBI in Q3 2022 and held it in 3 quarters. The position peaked at $310K in Q4 2022. 713 funds tracked by Wall St. Rank hold XBI as of Q2 2023.

Pictet Asset Management (Switzerland) reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2023 after selling out during the quarter.
Pictet Asset Management (Switzerland) sold 3,733 State Street SPDR S&P Biotech ETF shares in Q2 2023, an estimated $284K.
Pictet Asset Management (Switzerland) first reported a position in State Street SPDR S&P Biotech ETF in Q3 2022 and held it in 3 quarters.
Pictet Asset Management (Switzerland)'s State Street SPDR S&P Biotech ETF position peaked at $310K in Q4 2022.
713 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.